InsiderLens

15 juil. 2019SALESyros Pharmaceuticals, Inc.2 7008.27 USD

détention directe

16 juil. 2019SALESyros Pharmaceuticals, Inc.25 7797.81 USD

détention directe

17 juil. 2019SALESyros Pharmaceuticals, Inc.34 5217.70 USD

détention directe

03 avr. 2018PURCHASERuthigen, Inc.1 150 000—

indirect· See Footnotes

03 avr. 2018PURCHASERuthigen, Inc.1 150 000—

indirect· See Footnotesderiv

03 avr. 2018PURCHASERuthigen, Inc.1 150 000—

indirect· See Footnotesderiv

23 mai 2016SALEPHASERX, INC.484 9030.01 USD

indirect· By ARCH Venture Fund VII, L.P.

23 mai 2016PURCHASEPHASERX, INC.1 000 0005.00 USD

indirect· By ARCH Venture Fund VII, L.P.

23 mai 2016SALEPHASERX, INC.195 1560.01 USD

indirect· By ARCH Venture Fund VII, L.P.

23 mai 2016GRANT_AWARDPHASERX, INC.9 3850.00 USD

détention directederiv

23 juin 2014OTHERAGIOS PHARMACEUTICALS, INC.386 074—

détention directe

ARCH Venture Partners VII, L.P.